| Interventional group (n = 58) ₮ | Control group (n = 63) ¥ | Repeat measure ANOVA | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Pre-test | Post-treatment | Three-month follow-up | Pre-test | Post-treatment | Three-month follow-up | Time X Group | Time | Group | ||||||
Instrument | M | SD | M | SD | M | SD | M | SD | M | SD | M | SD | F | F | F |
KASQ (0–25)ª | 7.97 | 2.96 | 12.95 | 3.02 | 14.50 | 3.02 | 8.13 | 3.25 | 7.59 | 3.16 | 7.48 | 3.39 | 193.82*** | 128.85*** | 59.61*** |
PANSS (30–210) | 97.22 | 13.01 | 71.01 | 14.32 | 61.00 | 14.43 | 92.27 | 20.54 | 94.79 | 22.54 | 87.38 | 21.16 | 75.06*** | 105.72 *** | 27.29*** |
Primary caregivers | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
KASQ (0–25)ª | 9.45 | 4.30 | 15.71 | 3.41 | 16.74 | 3.28 | 8.22 | 3.82 | 7.80 | 3.67 | 7.51 | 3.68 | 186.55*** | 131.30*** | 96.31*** |
FBIS (0–48) | 28.26 | 7.22 | 21.86 | 6.67 | 18.84 | 6.63 | 25.44 | 8.32 | 26.98 | 8.66 | 26.22 | 8.33 | 73.94*** | 48.36 *** | 6.08* |
QOL(1–125) | 59.93 | 16.23 | 69.16 | 15.04 | 77.07 | 14.64 | 63.49 | 15.64 | 61.87 | 16.66 | 58.19 | 15.93 | 75.98*** | 21.70*** | 8.02** |